Congressional Dems Generating Heat, But No Hearings, On Rx Prices
This article was originally published in The Pink Sheet Daily
Executive Summary
House oversight committee Democrats want to subpoena Valeant Pharmaceuticals and hold a hearing with Turing Pharmaceuticals on drug price increases. Their requests may have more impact on investors than committee leadership, as the company saw a same-day stock decrease of 16%.